|
[1]AYUB A, ASHFAQ UA, HAQUE A.HBV induced HCC:major risk factors from genetic to molecular level[J].Biomed Res Int, 2013, 2013:810461.
|
|
[2] JEMAL A, BRAY F, CENTER M, et al.Global cancer statistics[J].CA Cancer J Clin, 2011, 61 (2) :69-90.
|
|
[3] LAU SH, SHAM JS, XIE D, et al.Clusterin plays an important role in hepatocellular carcinoma metastasis[J].Oncogene, 2006, 25 (8) :1242-1250.
|
|
[4]NAFEE AM, PASHA HF, ABD SM, et al.Clinical significance of serum clusterin as a biomarker for evaluating diagnosis and metastasis potential of viral-related hepatocellular carcinoma[J].Clin Biochem, 2012, 45 (13-14) :1070-1074.
|
|
[5]JUN CH, SIM DW, KIM SH, et al.Predictive factors for recurrence and survival in hepato-cellular carcinoma in South Korea[J].Anticancer Res, 2013, 33 (9) :4129-4134.
|
|
[6]LIU XL, LI FQ, LIU LX, et al.TNF-α, HGF and macrophage in peritumoural liver tissue relate to major risk factors of HCC recurrence[J].Hepatogastroenterology, 2013, 60 (125) :1121-1126.
|
|
[7]TROUGAKOS IP, DJEU JY, GONOS ES, et al.Advances and challenges in basic and translational research on clusterin[J].Cancer Res, 2009, 69 (2) :403-406.
|
|
[8]WYATT AR, YERBURY JJ, BERGHOFER P, et al.Clusterin facilitates in vivo clearance of extra-cellular misfolded proteins[J].Cell Mol Life Sci, 2011, 68 (23) :3919-3931.
|
|
[9]NOVINEC M, LENARCˇICˇB, BAICI A.Clusterin is a specific stabilizer and liberator of extracellular cathepsin K[J].FEBS Lett, 2012, 586 (7) :1062-1066.
|
|
[10]LAU SH, SHAM JS, XIE D, et al.Clusterin plays an important role in hepatocellular carcinoma metastasis[J].Oncogene, 2006, 25 (8) :1242-1250.
|
|
[11]COMUNALE MA, WANG M, RODEMICH-BETESH L, et al.Novel changes in glycosylation of serum Apo-J in patients with hepatocellular carcinoma[J].Cancer Epidemiol Biomarkers Prev, 2011, 20 (6) :1222-1229.
|
|
[12] NAFEE AM, PASHA HF, ABD EL AAL SM, et al.Clinical significance of serum clusterin as a biomarker for evaluating diagnosis and metastasis potential of viral-related hepatocellular carcinoma[J].Clin Biochem, 2012, 45 (13-14) :1070-1074.
|
|
[13]WANG Y, LIU YH, MAI SJ, et al.Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis[J].J Gastroenterol Hepatol, 2010, 25 (6) :1123-1128.
|
|
[14]LIU X, WAN X, LI Z, et al.Golgi protein 73 (GP73) , a useful serum marker in liver diseases[J].Clin Chem Lab Med, 2011, 49 (8) :1311-1316.
|
|
[15]TROUGAKOS IP, LOURDA M, ANTONELOU MH, et al.Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex[J].Clin Cancer Res, 2009, 15 (1) :48-59.
|
|
[16]WANG C, JIANG K, GAO D, et al.Clusterin protects hepatocellular carcinoma cells from endoplasmic reticulum stress induced apoptosis through GRP78[J].PLoS One, 2013, 8 (2) :e55981.
|
|
[17]ZOUBEIDI A, CHI K, GLEAVE M.Targeting the cytoprotective chaperone, clusterin, for treatment of advanced cancer[J].Clin Cancer Res, 2010, 16 (4) :1088-1097.
|
|
[18]XIU P, DONG X, DONG X, et al.Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma[J].Cancer Sci, 2013, 104 (3) :375-382.
|
|
[19]WANG C, JIANG K, KANG X, et al.Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis[J].Int J Biochem Cell Biol, 2012, 44 (12) :2308-2320.
|
|
[20]PORSCH H, BERNERT B, MEHIC'M, et al.Efficient TGFβ-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2[J].Oncogene, 2013, 32 (37) :4355-4365.
|
|
[21]YAN XD, DONG ZZ, YAO DF.Abnormal activation of insulinlike growth factor-I receptor in hepatocellular carcinoma and potential of IGF-IR targeted therapy[J].J Clin Hepatol, 2013, 29 (6) :473-476. (in Chinese) 严晓娣, 董志珍, 姚登福.胰岛素样生长因子-I受体异常激活与肝癌靶向治疗[J].临床肝胆病杂志, 2013, 29 (6) :473-476.
|
DownLoad: